Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_273326141

AstraZeneca to buy Alexion in $39 billion deal

December 14, 2020
Sales and Marketing Alexion, AstraZeneca, merger

British-Swedish AstraZeneca is set to acquire American biopharmaceutical company Alexion for $39 billion, in a move that will see a …

News
bavencio_merck_large

Pfizer and Merck KGaA secure CHMP recommendation for Bavencio in Europe for first-line maintenance of urothelial carcinoma

December 14, 2020
Sales and Marketing Bavencio, CHMP, EMA, Merck, Pfizer, pharma, urothelial carcinoma

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given its recommendation for …

News
european_commission

European approval for AstraZeneca’s Trixeo Aerospace in moderate to severe COPD

December 14, 2020
Sales and Marketing AstraZeneca, COPD, EMA, Europe, Trixeo Aerosphere

The European Medicines Agency (EMA) has announced the approval of AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) in the European Union …

News
shutterstock_95714119

Novartis and Incyte’s ruxolitinib fails to show benefit in COVID-19 at Phase 3

December 14, 2020
Research and Development, Sales and Marketing COVID-19, Incyte, Novartis

Novartis has unveiled that its JAK 1/2 tyrosine kinase inhibitor ruxolitinib fell short of its main efficacy goal in the …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 11, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, COVID-19, Pfizer, Vaccine, pharma, top 10

With just around three weeks until the end of a long year, rapidly emerging news around the leading COVID-19 vaccine …

News
spravato

Janssen’s esketamine nasal spray secures CHMP recommendation in Europe for the rapid reduction of depressive symptoms in a psychiatric emergency for patients with major depressive disorder

December 11, 2020
Medical Communications EMA, Europe, Spravato, depression

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has moved to recommend Janssen’s …

News
vaccination-1215279_960_720

Sanofi/GSK COVID-19 vaccine development delayed after failing to induce strong response in over-50s

December 11, 2020
Medical Communications, Research and Development COVID-19, GSK, Sanofi, Vaccine

Sanofi and GlaxoSmithKline have taken the decision to delay the development programme for their adjuvanted recombinant protein-based COVID-19 vaccine after …

News

FDA advisory panel recommends US approval of Pfizer/BioNTech’s COVID-19 vaccine

December 11, 2020
Medical Communications, Sales and Marketing COVID-19, FDA, Vaccine

An advisory panel on behalf of the FDA has strongly recommended that Pfizer and BioNTech’s COVID-19 vaccine BNT162b2 be approved …

News

NICE backs Novartis’ Aimovig for prevention of episodic and chronic migraine

December 11, 2020
Medical Communications, Sales and Marketing Aimovig, NICE, Novartis, migraine

NICE has announced its decision to recommended Novartis’ Aimovig (erenumab) for the prevention of migraine, including both episodic and chronic …

News
data_security

Hackers breach EMA server to steal data on Pfizer/BioNTech’s COVID-19 vaccine

December 10, 2020
Research and Development COVID-19, EMA, Vaccine

Pfizer and BioNTech’s jointly-developed COVID-19 vaccine, which this week began to rolled out to elderly patients in the UK after …

News

NICE authorises Takeda’s Alunbrig for ALK-positive advanced non-small cell lung cancer

December 10, 2020
Sales and Marketing ALK-positive advanced non-small cell lung cancer, Alunbrig, NICE, Takeda

NICE has published its final appraisal of Takeda’s Alunbrig (brigatinib), recommending the therapy for the treatment of ALK-positive advanced non-small …

News
injection

UAE reveals 86% effiacy for Sinopharm’s COVID-19 vaccine

December 10, 2020
Research and Development COVID-19, Sinopharm, UAE, Vaccine

The Health Ministry of the United Arab Emirates has unveiled the first known efficacy data for the COVID-19 vaccine candidate …

News
lilly_entrance_web

Lilly’s tirzepatide generates significant reductions in weight and blood sugar in type 2 diabetes patients

December 10, 2020
Research and Development Eli Lilly, diabetes, tirzepatide

Eli Lilly has announced new data for its glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide, showing …

News
abbvie_0

AbbVie unveils new Phase 3 upadacitinib data in moderate to severe ulcerative colitis

December 10, 2020
Research and Development AbbVie, upadacitinib

AbbVie has announced data from the first of two Phase 3 studies investigating the efficacy of upadacitinib in treating moderate …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Top 5, pharma

COVID-19 vaccine news continues to roll in and continues to be positive, with AstraZeneca now releasing Phase 3 data that …

News

Novartis’ Kisqali delays need for chemo by over 4 years in post-menopausal HR+HER2- metastatic breast cancer

December 9, 2020
Research and Development Kisqali, Novartis, breast cancer

Novartis has lifted the curtain on updated Phase 3 data for Kisqali (ribociclib) in the treatment of hormone receptor positive, …

News
img_4190-e1376666350337-web

MHRA warns patients with history of significant allergic reactions not to receive Pfizer/BioNTech COVID-19 vaccine

December 9, 2020
Research and Development COVID-19, MHRA, UK, Vaccine

While the rolling out of Pfizer and BioNTech’s COVID-19 in the UK this week marked a historic moment in a …

News
astrazeneca_plaque

AstraZeneca and Oxford Uni vaccine is safe and effective in preventing COVID-19 infection, Phase 3 data show

December 9, 2020
Research and Development AstraZeneca, COVID-19, Vaccine

The latest efficacy data on the COVID-19 vaccine developed by AstraZeneca in partnership with the University of Oxford have been …

News
shutter

Amryt’s Lojuxta approved in Brazil to reduce cholesterol in homozygous familial hypercholesterolaemia patients

December 9, 2020
Research and Development, Sales and Marketing Amryt, Brazil, rare disease

Brazil’s National Health Surveillance Agency (ANVISA) has moved to authorise Amryt’s Lojuxta (lomitapide) in the country as a treatment for …

News
credit_nhs_england

UK launches COVID-19 vaccination drive with first dosings of Pfizer/BioNTech’s candidate

December 8, 2020
Manufacturing and Production, Sales and Marketing COVID-19, UK, Vaccine

The first doses of Pfizer and BioNTech’s approved COVID-19 vaccine have been administered in the UK in a historic occasion …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026